SCHEMBL22889372

SCHEMBL22889372

c1ccc(-c2ccc(-c3nc(-c4cccc(-c5ccc6ccccc6c5)c4)nc(-c4cccc5c4oc4ccccc45)n3)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.45
ALDH1A1 P00352 5/20 0.40
KDM4E B2RXH2 4/20 0.40
HSD17B10 Q99714 3/20 0.40
TP53 P04637 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
CYP1A2 P05177 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPT P10636 6/20 0.39
POLB P06746 1/20 0.38
PLA2G2A P14555 2/20 0.38
PLA2G4A P47712 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
GGPS1 O95749 1/20 0.37
TSHR P16473 3/20 0.36
HPGD P15428 2/20 0.36
MAPK1 P28482 2/20 0.36
PRKDC P78527 2/20 0.36
NFKB1 P19838 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22889256 1.00 ALOX5 (0.45) ALOX5ALDH1A1KDM4EHSD17B10TP53
SCHEMBL22889379 0.99 ALOX5 (0.46) ALOX5ALDH1A1KDM4EHSD17B10TP53
SCHEMBL22889401 0.99 ALOX5 (0.46) ALOX5ALDH1A1KDM4EHSD17B10TP53
SCHEMBL22889267 0.99 ALOX5 (0.46) ALOX5ALDH1A1KDM4EHSD17B10TP53
SCHEMBL21304197 0.98 ALOX5 (0.47) ALOX5ALDH1A1KDM4EHSD17B10TP53
SCHEMBL22889190 0.98 ALOX5 (0.47) ALOX5ALDH1A1KDM4EHSD17B10TP53
SCHEMBL22889077 0.98 ALOX5 (0.47) ALOX5ALDH1A1KDM4EHSD17B10TP53
SCHEMBL21304198 0.98 ALOX5 (0.47) ALOX5ALDH1A1KDM4EHSD17B10TP53
SCHEMBL22888626 0.96 ALOX5 (0.46) ALOX5ALDH1A1KDM4EHSD17B10TP53
SCHEMBL23822400 0.96 ALOX5 (0.48) ALOX5ALDH1A1KDM4EHSD17B10TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2021-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, RPS4Y1, AR ALOX5 3163/4885ALDH1A1 1387/4885KDM4E 1801/4885
US-11765972-B2 Compound and organic electroluminescence device using the same AR, OR10J3, RPS4Y1 ALOX5 3071/4885ALDH1A1 1441/4885KDM4E 1945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.